LUNAR IIIb Study Comparing Rosuvastatin and Atorvastatin in Subjects With Acute Coronary Syndromes

• Status: Completed
• Trial end date: 2007-08-01
• Target enrollment: 0
• Participant gender: All

Summary

Comparison of rosuvastatin and atorvastatin in subjects with acute coronary syndromes

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: AstraZeneca
• Treatments: Atorvastatin; Atorvastatin Calcium; Calcium; Rosuvastatin Calcium

Criteria

Inclusion Criteria:

• Non-ST segment elevation ACS and ST segment elevation ACS who receive optimal reperfusion therapy

Exclusion Criteria:

• Previous Q-wave infarct within the last 4 weeks

• CK elevation not caused by myocardial injury

• uncontrolled hypertension at time of randomization